Hira S Mian (H Mian, Hira Mian)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 52

Top Topics

Multiple Myeloma

Systematic Review

Community Dwelling

Newly Diagnosed

Top Venues

Blood cancer journal

American journal of hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Hira S Mian, Hsien Seow, Amaris K Balitsky, Matthew C Cheung, Anastasia Gayowsky, Jason Tay, Tanya M Wildes, Arleigh McCurdy, Alissa Visram, Irwindeep Sandhu, Rinku Sutradhar
A Prognostic Survival Model Incorporating Patient-Reported Outcomes for Transplant-Ineligible Patients With Multiple Myeloma. The oncologist 29 (6) (2024)
Hira S Mian, Martin F Kaiser, Rafael Fonseca
Translocation t(14;16) in multiple myeloma: gangster or just part of the gang? Blood cancer journal 14 (1) (2024)
Karun Neupane, Gliceida Galarza Fortuna, Riyasha Dahal, Timothy Martin Schmidt, Rafael Fonseca, Rajshekhar Chakraborty, Kelly Ann Koehn, Meera Mohan, Hira S Mian, Luciano José Megale Costa, Douglas W Sborov, Ghulam Rehman Mohyuddin
Alterations in chromosome 1q in multiple myeloma randomized clinical trials: a systematic review. Blood cancer journal 14 (1) (2024)
Hira S Mian, Hsien Seow, Amaris K Balitsky, Matthew C Cheung, Anastasia Gayowsky, Jason Tay, Tanya M Wildes, Arleigh McCurdy, Alissa Visram, Irwindeep Sandhu, Rinku Sutradhar
A Prognostic Survival Model Incorporating Patient-Reported Outcomes for Transplant-Ineligible Patients With Multiple Myeloma. The oncologist (2024)
Hira S Mian, Hsien Seow, Amaris K Balitsky, Matthew C Cheung, Anastasia Gayowsky, Jason Tay, Tanya M Wildes, Arleigh McCurdy, Alissa Visram, Irwindeep Sandhu, Rinku Sutradhar
A Prognostic Survival Model Incorporating Patient-Reported Outcomes for Transplant-Ineligible Patients With Multiple Myeloma. The oncologist 29 (6) (2024)
Hira S Mian, Martin F Kaiser, Rafael Fonseca
Translocation t(14;16) in multiple myeloma: gangster or just part of the gang? Blood cancer journal 14 (1) (2024)
Laurent Garderet, Luuk Gras, Linda Koster, Laurien Baaij, Nada Hamad, Anita Dsouza, Noel Estrada-Merly, Parameswaran Hari, Wael Saber, Andrew J Cowan, Minako Iida, Shinichiro Okamoto, Hiroyuki Takamatsu, Shohei Mizuno, Koji Kawamura, Yoshihisa Kodera, Bor Sheng Ko, Christopher Liam, Kim Wah Ho, A Sim Goh, S Keat Tan, Alaa M Elhaddad, Ali Bazarbachi, Qamar Un Nisa Chaudhry, Rozan Alfar, Mohamed-Amine Bekadja, Malek Benakli, Cristobal Augusto Frutos Ortiz, Eloísa Riva, Sebastian Galeano, Francisca Bass, Hira S Mian, Arleigh McCurdy, Feng Rong Wang, Meng Lv, Daniel Neumann, Mickey Koh, John A Snowden, Stefan Schönland, Donal P McLornan, Patrick John Hayden, Anna Sureda, Hildegard T Greinix, Mahmoud Aljurf, Yoshiko Atsuta, Dietger Niederwieser
Global characteristics and outcomes of autologous hematopoietic stem cell transplantation for newly diagnosed multiple myeloma: A study of the worldwide network for blood and marrow transplantation (WBMT). American journal of hematology (2024)
Rayan Kaedbey, Donna Reece, Christopher P Venner, Arleigh McCurdy, Jiandong Su, Michael Chu, Martha Louzada, Victor H Jimenez-Zepeda, Hira S Mian, Kevin Song, Michael Sebag, Julie Stakiw, Darrell White, Anthony Reiman, Muhammad Aslam, Rami Kotb, Debra Bergstrom, Engin Gul, Richard LeBlanc
Long-term follow-up of outcomes including progression-free survival 2 in patients with transplant-ineligible multiple myeloma in the real-world practice: A multi-institutional report from the Canadian Myeloma Research Group (CMRG) database. EJHaem 5 (3) (2024)
Hira S Mian, Martin F Kaiser, Rafael Fonseca
Translocation t(14;16) in multiple myeloma: gangster or just part of the gang? Blood cancer journal 14 (1) (2024)
Rayan Kaedbey, Donna Reece, Christopher P Venner, Arleigh McCurdy, Jiandong Su, Michael Chu, Martha Louzada, Victor H Jimenez-Zepeda, Hira S Mian, Kevin Song, Michael Sebag, Julie Stakiw, Darrell White, Anthony Reiman, Muhammad Aslam, Rami Kotb, Debra Bergstrom, Engin Gul, Richard LeBlanc
Long-term follow-up of outcomes including progression-free survival 2 in patients with transplant-ineligible multiple myeloma in the real-world practice: A multi-institutional report from the Canadian Myeloma Research Group (CMRG) database. EJHaem 5 (3) (2024)
Hira S Mian, Martin F Kaiser, Rafael Fonseca
Translocation t(14;16) in multiple myeloma: gangster or just part of the gang? Blood cancer journal 14 (1) (2024)
Hira S Mian, Hsien Seow, Amaris K Balitsky, Matthew C Cheung, Anastasia Gayowsky, Jason Tay, Tanya M Wildes, Arleigh McCurdy, Alissa Visram, Irwindeep Sandhu, Rinku Sutradhar
A Prognostic Survival Model Incorporating Patient-Reported Outcomes for Transplant-Ineligible Patients With Multiple Myeloma. The oncologist 29 (6) (2024)
Rajshekhar Chakraborty, Hira S Mian
Quadruplets in newly diagnosed transplant-ineligible multiple myeloma. American journal of hematology (2024)
Karun Neupane, Gliceida Galarza Fortuna, Riyasha Dahal, Timothy Martin Schmidt, Rafael Fonseca, Rajshekhar Chakraborty, Kelly Ann Koehn, Meera Mohan, Hira S Mian, Luciano José Megale Costa, Douglas W Sborov, Ghulam Rehman Mohyuddin
Alterations in chromosome 1q in multiple myeloma randomized clinical trials: a systematic review. Blood cancer journal 14 (1) (2024)
Hira S Mian, Martin F Kaiser, Rafael Fonseca
Translocation t(14;16) in multiple myeloma: gangster or just part of the gang? Blood cancer journal 14 (1) (2024)
Karun Neupane, Gliceida Galarza Fortuna, Riyasha Dahal, Timothy Martin Schmidt, Rafael Fonseca, Rajshekhar Chakraborty, Kelly Ann Koehn, Meera Mohan, Hira S Mian, Luciano José Megale Costa, Douglas W Sborov, Ghulam Rehman Mohyuddin
Alterations in chromosome 1q in multiple myeloma randomized clinical trials: a systematic review. Blood cancer journal 14 (1) (2024)
Karun Neupane, Gliceida Galarza Fortuna, Riyasha Dahal, Timothy Martin Schmidt, Rafael Fonseca, Rajshekhar Chakraborty, Kelly Ann Koehn, Meera Mohan, Hira S Mian, Luciano José Megale Costa, Douglas W Sborov, Ghulam Rehman Mohyuddin
Alterations in chromosome 1q in multiple myeloma randomized clinical trials: a systematic review. Blood cancer journal 14 (1) (2024)
Hira S Mian, Martin Kaiser, Rafael Fonseca
Still high risk? A review of translocation t(14;16) in multiple myeloma. American journal of hematology (2024)
Karun Neupane, Gliceida Galarza Fortuna, Riyasha Dahal, Timothy Martin Schmidt, Rafael Fonseca, Rajshekhar Chakraborty, Kelly Ann Koehn, Meera Mohan, Hira S Mian, Luciano José Megale Costa, Douglas W Sborov, Ghulam Rehman Mohyuddin
Alterations in chromosome 1q in multiple myeloma randomized clinical trials: a systematic review. Blood cancer journal 14 (1) (2024)
Karun Neupane, Gliceida Galarza Fortuna, Riyasha Dahal, Timothy Martin Schmidt, Rafael Fonseca, Rajshekhar Chakraborty, Kelly Ann Koehn, Meera Mohan, Hira S Mian, Luciano José Megale Costa, Douglas W Sborov, Ghulam Rehman Mohyuddin
Alterations in chromosome 1q in multiple myeloma randomized clinical trials: a systematic review. Blood cancer journal 14 (1) (2024)
Arleigh McCurdy, Hira S Mian, Richard LeBlanc, Victor H Jimenez-Zepeda, Jiandong Su, Esther Masih-Khan, Alissa Visram, Martha Louzada, Kevin Song, Darrell White, Michael Sebag, Julie Stakiw, Anthony Reiman, Muhammad Aslam, Debra Bergstrom, Rami Kotb, Rayan Kaedbey, Engin Gul, Donna Reece, Christopher P Venner
Correction: Redefining attrition in multiple myeloma (MM): a Canadian Myeloma Research Group (CMRG) analysis. Blood cancer journal 13 (1) (2023)
Hira S Mian, Tanya M Wildes, Ravi Vij, Matthew J Pianko, Ajay Major, Mark A Fiala
Dynamic frailty risk assessment among older adults with multiple myeloma: A population-based cohort study. Blood cancer journal 13 (1) (2023)
Hira S Mian, Tanya M Wildes, Ravi Vij, Matthew J Pianko, Ajay Major, Mark A Fiala
Dynamic frailty risk assessment among older adults with multiple myeloma: A population-based cohort study. Blood cancer journal 13 (1) (2023)
Naresh Bumma, Binod Dhakal, Raphael Fraser, Noel Estrada-Merly, Kenneth Anderson, César O Freytes, Gerhard C Hildebrandt, Leona Holmberg, Maxwell M Krem, Cindy Lee, Lazaros Lekakis, Hillard M Lazarus, Hira S Mian, Hemant S Murthy, Sunita Nathan, Taiga Nishihori, Ricardo D Parrondo, Sagar S Patel, Melhem Solh, Christopher Strouse, David H Vesole, Shaji K Kumar, Muzaffar H Qazilbash, Nina Shah, Anita D Souza, Surbhi Sidana
Impact of bortezomib-based versus lenalidomide maintenance therapy on outcomes of patients with high-risk multiple myeloma. Cancer (2023)
Hira S Mian, Tanya M Wildes, Christopher P Venner, Rafael Fonseca
MRD negativity: considerations for older adults with multiple myeloma. Blood cancer journal 13 (1) (2023)
Arleigh McCurdy, Hira S Mian, Richard LeBlanc, Victor H Jimenez-Zepeda, Jiandong Su, Esther Masih-Khan, Alissa Visram, Martha Louzada, Kevin Song, Darrell White, Michael Sebag, Julie Stakiw, Anthony Reiman, Muhammad Aslam, Debra Bergstrom, Rami Kotb, Rayan Kaedbey, Engin Gul, Donna Reece, Christopher P Venner
Redefining attrition in multiple myeloma (MM): a Canadian Myeloma Research Group (CMRG) analysis. Blood cancer journal 13 (1) (2023)
Hira S Mian, Arleigh McCurdy, Smith Giri, Shakira J Grant, Bram Rochwerg, Erica Winks, Ashley E Rosko, Monika Engelhardt, Charlotte Pawlyn, Curly T C M Morris, Graham Jackson, Sara Bringhen, Thierry Facon, Alessandra Larocca, Sonja Zweegman, Tanya M Wildes
The prevalence and outcomes of frail older adults in clinical trials in multiple myeloma: A systematic review. Blood cancer journal 13 (1) (2023)
Hira S Mian, Arleigh McCurdy, Smith Giri, Shakira J Grant, Bram Rochwerg, Erica Winks, Ashley E Rosko, Monika Engelhardt, Charlotte Pawlyn, Curly T C M Morris, Graham Jackson, Sara Bringhen, Thierry Facon, Alessandra Larocca, Sonja Zweegman, Tanya M Wildes
The prevalence and outcomes of frail older adults in clinical trials in multiple myeloma: A systematic review. Blood cancer journal 13 (1) (2023)
Julie Côté, Richard LeBlanc, Hira S Mian, Michael P Chu, Arleigh McCurdy, Esther Masih-Khan, Jiandong Su, Victor H Jimenez-Zepeda, Kevin Song, Martha Louzada, Darrell White, Michael Sebag, Anthony Reiman, Julie Stakiw, Rami Kotb, Debra Bergstrom, Muhammad Aslam, Rayan Kaedbey, Christopher P Venner, Engin Gul, Donna Reece
Real-world results of autologous stem cell transplantation in newly diagnosed multiple myeloma: a report from the Canadian Myeloma Research Group database. Blood cancer journal 13 (1) (2023)
Hira S Mian, Arleigh McCurdy, Smith Giri, Shakira J Grant, Bram Rochwerg, Erica Winks, Ashley E Rosko, Monika Engelhardt, Charlotte Pawlyn, Curly T C M Morris, Graham Jackson, Sara Bringhen, Thierry Facon, Alessandra Larocca, Sonja Zweegman, Tanya M Wildes
The prevalence and outcomes of frail older adults in clinical trials in multiple myeloma: A systematic review. Blood cancer journal 13 (1) (2023)
Alissa Visram, Hsien Seow, Mark A Fiala, Anastasia Gayowsky, Matthew C Cheung, Gwynivere Davies, Gregory R Pond, Hira S Mian
Socioeconomic marginalization and health outcomes in newly diagnosed multiple myeloma: A population-based cohort study. American journal of hematology (2023)
Hira S Mian, Arleigh McCurdy, Smith Giri, Shakira J Grant, Bram Rochwerg, Erica Winks, Ashley E Rosko, Monika Engelhardt, Charlotte Pawlyn, Curly T C M Morris, Graham Jackson, Sara Bringhen, Thierry Facon, Alessandra Larocca, Sonja Zweegman, Tanya M Wildes
The prevalence and outcomes of frail older adults in clinical trials in multiple myeloma: A systematic review. Blood cancer journal 13 (1) (2023)
Hira S Mian, Tanya M Wildes, Ravi Vij, Matthew J Pianko, Ajay Major, Mark A Fiala
Dynamic frailty risk assessment among older adults with multiple myeloma: A population-based cohort study. Blood cancer journal 13 (1) (2023)
Hira S Mian, Arleigh McCurdy, Smith Giri, Shakira J Grant, Bram Rochwerg, Erica Winks, Ashley E Rosko, Monika Engelhardt, Charlotte Pawlyn, Curly T C M Morris, Graham Jackson, Sara Bringhen, Thierry Facon, Alessandra Larocca, Sonja Zweegman, Tanya M Wildes
The prevalence and outcomes of frail older adults in clinical trials in multiple myeloma: A systematic review. Blood cancer journal 13 (1) (2023)
Hira S Mian, Tanya M Wildes, Ravi Vij, Matthew J Pianko, Ajay Major, Mark A Fiala
Dynamic frailty risk assessment among older adults with multiple myeloma: A population-based cohort study. Blood cancer journal 13 (1) (2023)
Alissa Visram, A De La Torre, D White, J Su, E Masih-Khan, M Chu, V Jimenez-Zepeda, Arleigh McCurdy, R LeBlanc, K Song, Hira S Mian, M Louzada, M Sebag, D Bergstrom, J Stakiw, A Reiman, R Kotb, M Aslam, C Venner, R Kaedbey, Engin Gul, D Reece
Real world data on outcomes of anti-CD38 antibody treated, including triple class refractory, patients with multiple myeloma: a multi-institutional report from the Canadian Myeloma Research Group (CMRG) Database. Blood cancer journal 13 (1) (2023)
Richard LeBlanc, Hira S Mian, Donna Reece, Jiandong Su, Esther Masih-Khan, Michael Chu, Victor H Jimenez-Zepeda, Michael Sebag, Kevin Song, Martha Louzada, Rami Kotb, Alissa Visram, Darrell White, Julie Stakiw, Anthony Reiman, Muhammad Aslam, Debra Bergstrom, Rayan Kaedbey, Engin Gul, Christopher P Venner
Outcome of carfilzomib/pomalidomide-based regimens after daratumumab-based treatment in relapsed multiple myeloma: A Canadian Myeloma Research Group Database analysis. European journal of haematology (2023)
Evguenia Ouchveridze, Rahul Banerjee, Aakash Desai, Muhammad Aziz, Wade Lee-Smith, Hira S Mian, Katherine Berger, Brian McClune, Douglas W Sborov, Muzaffar H Qazilbash, Shaji K Kumar, Ghulam Rehman Mohyuddin
Financial toxicity in hematological malignancies: a systematic review. Blood cancer journal 12 (4) (2022)
Ghulam Rehman Mohyuddin, Rajshekhar Chakraborty, Gregory Sampang Calip, Mustafa S Ascha, Xiaoliang Wang, Samuel M Rubinstein, Sascha A Tuchman, Luciano José Megale Costa, Benjamin Haaland, Smith Giri, Hira S Mian, Rafael Fonseca, Douglas W Sborov
Prognostic value of translocation 11;14 in patients with relapsed/refractory myeloma receiving anti-CD38 therapy. Blood cancer journal 12 (12) (2022)
Ghulam Rehman Mohyuddin, Aynharan Sinnarajah, Anastasia Gayowsky, Kelvin K W Chan, Hsien Seow, Hira S Mian
Quality of end-of-life care in multiple myeloma: A 13-year analysis of a population-based cohort in Ontario, Canada. British journal of haematology 199 (5) (2022)
Ghulam Rehman Mohyuddin, Rajshekhar Chakraborty, Gregory Sampang Calip, Mustafa S Ascha, Xiaoliang Wang, Samuel M Rubinstein, Sascha A Tuchman, Luciano José Megale Costa, Benjamin Haaland, Smith Giri, Hira S Mian, Rafael Fonseca, Douglas W Sborov
Prognostic value of translocation 11;14 in patients with relapsed/refractory myeloma receiving anti-CD38 therapy. Blood cancer journal 12 (12) (2022)
Ghulam Rehman Mohyuddin, Rajshekhar Chakraborty, Gregory Sampang Calip, Mustafa S Ascha, Xiaoliang Wang, Samuel M Rubinstein, Sascha A Tuchman, Luciano José Megale Costa, Benjamin Haaland, Smith Giri, Hira S Mian, Rafael Fonseca, Douglas W Sborov
Prognostic value of translocation 11;14 in patients with relapsed/refractory myeloma receiving anti-CD38 therapy. Blood cancer journal 12 (12) (2022)
Hira S Mian, Rinku Sutradhar, Gregory R Pond, Branavan Sivapathasundaram, Jonathan Sussman, Amaris Balitsky, Anita D Souza, Tanya M Wildes, Hsien Seow
Patient-reported outcome measures are associated with health care utilization in patients with transplant ineligible multiple myeloma: a population-based study. Blood cancer journal 12 (1) (2022)
Ghulam Rehman Mohyuddin, Rajshekhar Chakraborty, Gregory Sampang Calip, Mustafa S Ascha, Xiaoliang Wang, Samuel M Rubinstein, Sascha A Tuchman, Luciano José Megale Costa, Benjamin Haaland, Smith Giri, Hira S Mian, Rafael Fonseca, Douglas W Sborov
Prognostic value of translocation 11;14 in patients with relapsed/refractory myeloma receiving anti-CD38 therapy. Blood cancer journal 12 (12) (2022)
Arleigh McCurdy, Martha Louzada, Christopher P Venner, Alissa Visram, Esther Masih-Khan, Moustafa Kardjadj, Victor H Jimenez-Zepeda, Richard LeBlanc, Michael Sebag, Kevin Song, Darrell White, Hira S Mian, Julie Stakiw, Anthony Reiman, Muhammad Aslam, Rami Kotb, Engin Gul, Donna Reece
Carfilzomib usage patterns and outcomes in patients with relapsed multiple myeloma: A multi-institutional report from the Canadian Myeloma Research Group (CMRG) Database. EJHaem 3 (4) (2022)
Ghulam Rehman Mohyuddin, Rajshekhar Chakraborty, Gregory Sampang Calip, Mustafa S Ascha, Xiaoliang Wang, Samuel M Rubinstein, Sascha A Tuchman, Luciano José Megale Costa, Benjamin Haaland, Smith Giri, Hira S Mian, Rafael Fonseca, Douglas W Sborov
Prognostic value of translocation 11;14 in patients with relapsed/refractory myeloma receiving anti-CD38 therapy. Blood cancer journal 12 (12) (2022)
Ghulam Rehman Mohyuddin, Rajshekhar Chakraborty, Gregory Sampang Calip, Mustafa S Ascha, Xiaoliang Wang, Samuel M Rubinstein, Sascha A Tuchman, Luciano José Megale Costa, Benjamin Haaland, Smith Giri, Hira S Mian, Rafael Fonseca, Douglas W Sborov
Prognostic value of translocation 11;14 in patients with relapsed/refractory myeloma receiving anti-CD38 therapy. Blood cancer journal 12 (12) (2022)
Raleigh Ayoolu Fatoki, Kelly Koehn, Amar H Kelkar, Samer Al Hadidi, Nikita Mehra, Hira S Mian, Carl Ola Landgren, Dickran Kazandjian, James Hoffman, Douglas W Sborov, Ghulam Rehman Mohyuddin
Global Myeloma Trial Participation and Drug Access in the Era of Novel Therapies. JCO global oncology 8 (2022)
Hira S Mian, Smith Giri, Tanya M Wildes, Amaris K Balitsky, Arleigh McCurdy, Gregory R Pond, Branavan Sivapathasundaram, Hsien Seow
External validation of the FIRST trial's simplified frailty score in a population-based cohort. Leukemia 35 (6) (2021)
Carlyn Rose Tan, Noel Estrada-Merly, Heather J Landau, Lazaros Lekakis, Rahul Banerjee, Hira S Mian, Saad Z Usmani, Amr Hanbali, Hillard M Lazarus, Robert A Kyle, Bhagirathbhai R Dholaria, Susan Bal, Christopher S Strouse, Hemant S Murthy, Baldeep Wirk, Taiga Nishihori, Shaji K Kumar, Nina Shah, Muzaffar H Qazilbash, Anita D Souza
A second autologous hematopoietic cell transplantation is a safe and effective salvage therapy in select relapsed or refractory AL amyloidosis patients. Bone marrow transplantation (2021)
Oren Pasvolsky, Moshe Yeshurun, Raphael Fraser, Noel Estrada-Merly, Uri Rozovski, Liat Shargian-Alon, Amer Assal, Rahul Banerjee, Naresh Bumma, Robert Peter Gale, Patrick Hagen, Leona Holmberg, Nasheed M Hossain, Hillard M Lazarus, Cindy Lee, Hira S Mian, Kevin C Miller, Sunita Nathan, Arnon Nagler, Taiga Nishihori, Ricardo D Parrondo, Sagar S Patel, Mark G Frattini, Saad Z Usmani, Trent P Wang, Baldeep Wirk, Shaji K Kumar, Nina Shah, Muzaffar H Qazilbash, Anita D Souza
Maintenance therapy after second autologous hematopoietic cell transplantation for multiple myeloma. A CIBMTR analysis. Bone marrow transplantation (2021)
Hira S Mian, Mark A Fiala, Larysa Sanchez, Ravi Vij, Tanya M Wildes
Renal failure among multiple myeloma patients utilizing carfilzomib and associated factors in the "real world". Annals of hematology 100 (5) (2021)